Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Acq. announced
Appointed director
TherapeuticsMD, Inc. (TXMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/14/2023 8-K Quarterly results
Docs: "FORM 8-K",
"TherapeuticsMD Announces Second Quarter 2023 Financial Results"
07/10/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Letter of Grant Thornton LLP"
07/06/2023 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial ...
Docs: "Fourth Amendment to Bylaws of the Company"
05/05/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
04/21/2023 8-K Quarterly results
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amendment, to the Employment Agreement, as extended effective October 15, 2021, by and between TherapeuticsMD, Inc. and Marlan Walker",
"General Consulting and Services Agreement by and between TherapeuticsMD, Inc. and MCD Consulting Management Services, LLC"
01/18/2023 8-K Quarterly results
01/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/06/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Pro Forma Financial Statements with Respect to the Transformation of the Company"
01/03/2023 8-K Resignation/termination of a director
Docs: "TherapeuticsMD Completes Transaction to License its Products to Mayne Pharma"
12/05/2022 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
09/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers"
08/29/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/15/2022 8-K Quarterly results
08/01/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Certificate of Designation, Preferences and Rights of Series A Preferred Stock",
"Third Amendment to Bylaws of the Company",
"Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP",
"Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TOA Talents, LLC",
"Amendment No. 16 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV Talents, LLC and Tao Talents, LLC",
"TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital"
07/29/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
07/25/2022 8-K Quarterly results
07/14/2022 8-K Quarterly results
06/06/2022 8-K/A Quarterly results
06/03/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/27/2022 8-K Other Events  Interactive Data
04/20/2022 8-K Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligati...
Docs: "Pro Forma Financial Statements with Respect to Disposition of vitaCare Prescription Services, Inc"
04/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million"
03/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy